[go: up one dir, main page]

DE3668168D1 - Desmosinderivate und reagenz zur herstellung artifizieller antigene. - Google Patents

Desmosinderivate und reagenz zur herstellung artifizieller antigene.

Info

Publication number
DE3668168D1
DE3668168D1 DE8686103706T DE3668168T DE3668168D1 DE 3668168 D1 DE3668168 D1 DE 3668168D1 DE 8686103706 T DE8686103706 T DE 8686103706T DE 3668168 T DE3668168 T DE 3668168T DE 3668168 D1 DE3668168 D1 DE 3668168D1
Authority
DE
Germany
Prior art keywords
desmosin
reagent
derivatives
production
artificial antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686103706T
Other languages
English (en)
Inventor
Takashi Matsumoto
Takashi Okada
Shigenobu Mizuzaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Application granted granted Critical
Publication of DE3668168D1 publication Critical patent/DE3668168D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/20—Surgical microscopes characterised by non-optical aspects

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
DE8686103706T 1985-03-25 1986-03-19 Desmosinderivate und reagenz zur herstellung artifizieller antigene. Expired - Fee Related DE3668168D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5815285 1985-03-25

Publications (1)

Publication Number Publication Date
DE3668168D1 true DE3668168D1 (de) 1990-02-15

Family

ID=13076015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686103706T Expired - Fee Related DE3668168D1 (de) 1985-03-25 1986-03-19 Desmosinderivate und reagenz zur herstellung artifizieller antigene.

Country Status (4)

Country Link
US (1) US4723012A (de)
EP (1) EP0196007B1 (de)
JP (1) JPS625962A (de)
DE (1) DE3668168D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841055A (en) * 1985-03-25 1989-06-20 Japan Tobacco Inc. Desmosine derivatives and reagent for preparing artificial antigens
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
JP4891136B2 (ja) * 2007-04-18 2012-03-07 株式会社第一印刷 糊綴じ冊子、糊綴じ冊子の製造方法、並びに糊綴じ冊子の製造装置
US20130273580A1 (en) * 2012-04-17 2013-10-17 Barry C. Starcher Elisa assay kit, elisa for determining desmosine levels from urine samples and diagnostic urine assays for aneurysms
CN104981456B (zh) * 2013-02-01 2017-12-19 学校法人上智学院 锁链素、异锁链素以及它们的衍生物的制造方法
JP7195568B2 (ja) * 2018-03-22 2022-12-26 学校法人上智学院 複合体

Also Published As

Publication number Publication date
EP0196007A2 (de) 1986-10-01
JPH0222067B2 (de) 1990-05-17
US4723012A (en) 1988-02-02
EP0196007A3 (en) 1988-01-07
JPS625962A (ja) 1987-01-12
EP0196007B1 (de) 1990-01-10

Similar Documents

Publication Publication Date Title
DE3687646D1 (de) Biosensor und dessen herstellung.
DE3668168D1 (de) Desmosinderivate und reagenz zur herstellung artifizieller antigene.
ES556881A0 (es) Procedimiento para la fabricacion de perlas vitreas
DE3678857D1 (de) Keramikverbundkoerper und verfahren zu ihrer herstellung.
DE3674906D1 (de) Selbstklemmende medizinische prothese und ihre herstellung.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
DE68925280D1 (de) Datenstromkoppler und methode der herstellung und zusammenstellung desselben
DE3685282D1 (de) Rhombohedrisches polykristallines bornitrid und dessen herstellung.
DE3684678D1 (de) Intraokulare linse und verfahren zur herstellung.
NO890970L (no) Fremgangsmaate for fremstilling av cykliske sulfater.
ATE42273T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1diethylaminocarbonyl-2-aminomethyl-cyclopropanhydrochlorid.
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
DE3671621D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE3679430D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE3682491D1 (de) Immobilisierter c-peptid-antikoerper, seine herstellung und verwendung.
NO861772L (no) Fremgangsmaate for fremstilling av proteinhydrolysat.
DE3688212D1 (de) Streckblasgeformter behaelter aus polyarylaenthioaether und herstellung davon.
ES556391A0 (es) Procedimiento para la fabricacion de perlas vitreas
DE3673674D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
ATE59634T1 (de) Verfahren zur herstellung von dialkyldisulfiden.
DE3672239D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE3680597D1 (de) Glaskeramischer gegenstand und verfahren zur herstellung desselben.
DE3670289D1 (de) Verfahren zur herstellung von aryl-glycidyl-aethern und von 3-substituierten 1-alkylamino-2-propanolen.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
DE3671603D1 (de) Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee